
HKSEBasic MaterialsChemicals - Specialty
Latest quote
HK$0.217
−HK$0.008 · -3.56%
Changmao Biochemical Engineering Company Limited, along with its affiliates, focuses on the production and global sale of organic acids. These products serve diverse industries, including food additive manufacturing, chemical production, and pharmaceuticals, reaching markets across Mainland China, Europe, the Asia Pacific region, the United States, and other international territories. Their extensive product line features fumaric acid, maleic acid, various forms of malic acid (L-, D-, and DL-), L(+)-, D(-)-, and DL-tartaric acids, L-aspartic acid, and aspartame. These compounds are utilized as essential food additives, pharmaceutical excipients, and active pharmaceutical ingredients, among other uses. Furthermore, the company is actively engaged in the research and development of medicinal and nutraceutical products, the manufacturing and distribution of additional food additives, the trade of organic acids, and property investment. Founded in 1992, Changmao Biochemical Engineering Company Limited is headquartered in Changzhou, People's Republic of China.
Latest quote
HK$0.217
−HK$0.008 · -3.56%
Changmao Biochemical Engineering Company Limited, along with its affiliates, focuses on the production and global sale of organic acids. These products serve diverse industries, including food additive manufacturing, chemical production, and pharmaceuticals, reaching markets across Mainland China, Europe, the Asia Pacific region, the United States, and other international territories. Their extensive product line features fumaric acid, maleic acid, various forms of malic acid (L-, D-, and DL-), L(+)-, D(-)-, and DL-tartaric acids, L-aspartic acid, and aspartame. These compounds are utilized as essential food additives, pharmaceutical excipients, and active pharmaceutical ingredients, among other uses. Furthermore, the company is actively engaged in the research and development of medicinal and nutraceutical products, the manufacturing and distribution of additional food additives, the trade of organic acids, and property investment. Founded in 1992, Changmao Biochemical Engineering Company Limited is headquartered in Changzhou, People's Republic of China.
52-week range
Current HK$0.217
Historical prices · Market data may be delayed.
Changmao Biochemical Engineering Company Limited, along with its affiliates, focuses on the production and global sale of organic acids. These products serve diverse industries, including food additive manufacturing, chemical production, and pharmaceuticals, reaching markets across Mainland China, Europe, the Asia Pacific region, the United States, and other international territories. Their extensive product line features fumaric acid, maleic acid, various forms of malic acid (L-, D-, and DL-), L(+)-, D(-)-, and DL-tartaric acids, L-aspartic acid, and aspartame. These compounds are utilized as essential food additives, pharmaceutical excipients, and active pharmaceutical ingredients, among other uses. Furthermore, the company is actively engaged in the research and development of medicinal and nutraceutical products, the manufacturing and distribution of additional food additives, the trade of organic acids, and property investment. Founded in 1992, Changmao Biochemical Engineering Company Limited is headquartered in Changzhou, People's Republic of China.
52-week range
Current HK$0.217
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 556.93M CNY | 584.79M CNY | 637.08M CNY | 730.03M CNY | 547.98M CNY |
| Cost of goods sold | 528.36M CNY | 568.02M CNY | 611.27M CNY | 549.2M CNY | 509.3M CNY |
| Gross profit | 28.57M CNY | 16.78M CNY | 25.81M CNY | 180.83M CNY | 38.68M CNY |
| Research and development | 6.32M CNY | 10.74M CNY | — | 13.92M CNY | 12.65M CNY |
| Selling, general, and administrative | 75.63M CNY | 81.02M CNY | 83.31M CNY | 96.97M CNY | 81.7M CNY |
| Operating expenses | 76.94M CNY | 73.85M CNY | 77.86M CNY | 91.46M CNY | −47.14M CNY |
| Interest income | 615.64K CNY | 846K CNY | 1.05M CNY | 940K CNY | 537K CNY |
| Interest expense | 16.78M CNY | 11.36M CNY | 7.58M CNY | 2.67M CNY | 1.95M CNY |
| Depreciation and amortization | 51.2M CNY | 39.68M CNY | 42.75M CNY | 32.2M CNY | 29.21M CNY |
| Operating income | −48.37M CNY | −57.07M CNY | −52.05M CNY | 89.37M CNY | 85.82M CNY |
| Net income | −66.76M CNY | −68.24M CNY | −86.06M CNY | 81.42M CNY | 58.32M CNY |
Company facts updated Sep 9, 2026.
Recent quarterly results
Recent quarterly results
Cash distributions grouped by calendar year; partial years are marked.
HK$0.0868
2023 complete year+284.8% since 2017
HK$0.0226
2,017
HK$0.0581
2,019
HK$0.0601
2,020
HK$0.0241
2,021
HK$0.0868
2,023
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | May 22, 2023 | HK$0.0868Irregular | May 24, 2023 | Jul 18, 2023 |
Dividend | May 24, 2021 | HK$0.0241Annual | May 25, 2021 | Jul 30, 2021 |
Dividend | May 27, 2020 | HK$0.0601Annual | May 28, 2020 | Jul 31, 2020 |
Dividend | May 15, 2019 | HK$0.0581Annual | May 16, 2019 | Jul 31, 2019 |
Dividend | May 16, 2017 | HK$0.0226Annual | May 17, 2017 | Jul 31, 2017 |
Dividend | May 18, 2016 | HK$0.031Annual | — | — |
Ex-dividend May 22, 2023
HK$0.0868
Irregular
Record May 24, 2023 · Payment Jul 18, 2023
Ex-dividend May 24, 2021
HK$0.0241
Annual
Record May 25, 2021 · Payment Jul 30, 2021
Ex-dividend May 27, 2020
HK$0.0601
Annual
Record May 28, 2020 · Payment Jul 31, 2020
Ex-dividend May 15, 2019
HK$0.0581
Annual
Record May 16, 2019 · Payment Jul 31, 2019
Ex-dividend May 16, 2017
HK$0.0226
Annual
Record May 17, 2017 · Payment Jul 31, 2017
Ex-dividend May 18, 2016
HK$0.031
Annual
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.